Replies to post #377977 on Elite Pharmaceuticals Inc (ELTP)

[jammy32]

I think he has signed contracts in hand. Just can’t announce yet

[Just give me $1.50]

Because people aren't factoring in the additional following:

1. Vigabatrin - Launching 2nd half of 2023.
2. Adderall IR - Launching in Israel this year.
3. Adderall IR/XR - Launching in another country in addition to Israel this year.
4. Dopamine Agonist - Launching FY2024 Q4.
5. Doxycycline - Launch to be determined.

He would not have thrown that $40 million out there if he did not have something to hang his hat on.